相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration
Chen Liu et al.
THERANOSTICS (2019)
BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC
Mingchen Ba et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma
Jingyuan Wang et al.
CANCER LETTERS (2018)
Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming
Ralph Stadhouders et al.
NATURE GENETICS (2018)
BRD4 regulates cellular senescence in gastric cancer cells via E2F/miR-106b/p21 axis
Xingchen Dong et al.
CELL DEATH & DISEASE (2018)
Identification of Nidogen 1 as a lung metastasis protein through secretome analysis
Masa Aleckovic et al.
GENES & DEVELOPMENT (2017)
Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC
Sander B. Frank et al.
JOURNAL OF CELL SCIENCE (2017)
The interplay of epigenetic marks during stem cell differentiation and development
Yaser Atlasi et al.
NATURE REVIEWS GENETICS (2017)
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
Valentina Sancisi et al.
NUCLEIC ACIDS RESEARCH (2017)
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors
Kun Qu et al.
CANCER CELL (2017)
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
Mark L. McCleland et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu et al.
NATURE (2016)
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
M. Ryan Corces et al.
NATURE GENETICS (2016)
BET inhibition as a new strategy for the treatment of gastric cancer
Raquel C. Montenegro et al.
ONCOTARGET (2016)
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Karine A. Cohen-Solal et al.
MOLECULAR CANCER (2015)
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert et al.
NATURE (2015)
Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
Dhong Hyun Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones
Tomohiko Kanno et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
Federico Andreoli et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D. Buenrostro et al.
NATURE METHODS (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Christopher J. Ott et al.
BLOOD (2012)
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
William W. Lockwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Updates on esophageal and gastric cancers
Amy Gallo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
分享论文
